{"filings":[{"id":1472078,"accession_number":"0000885978-26-000039","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2026-07-06T20:22:02+00:00","items":["8.01","9.01"],"status":"ready","headline":"USPH acquires 67% stake in 12-clinic PT practice; adds 45th state","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["USPH acquired a 67% equity interest; 33% retained by current owners.","Practice generates ~112,000 annual visits and $12 million in annual revenue.","Acquisition expands USPH's footprint from 44 to 45 states.","Acquisition effective July 1, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":528477,"accession_number":"0000885978-26-000027","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2026-05-19T20:50:19+00:00","items":["5.07"],"status":"ready","headline":"USPH shareholders elect directors, approve say-on-pay and auditor at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Seven directors elected with large majorities; highest vote for Peter F. Minan (14,005,301 for, 102,931 withheld).","Say-on-pay advisory proposal passed with 13,203,434 votes for, 894,885 against, and 494,670 broker non-votes.","Ratification of Grant Thornton LLP as auditor for FY 2026 approved with 14,475,354 for, 126,323 against, 1,225 abstaining."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":15282,"accession_number":"0000885978-26-000024","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2026-05-11T21:12:18+00:00","items":["7.01","9.01"],"status":"ready","headline":"USPH discusses Q1 2026 results on conference call; no specific financials in filing","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Conference call held May 7, 2026 to review Q1 2026 results.","Transcript furnished as Exhibit 99.1 provides no financial data in the portion shown.","Updated investor presentation furnished as Exhibit 99.2; not included in filing text.","No revenue, EPS, or guidance figures disclosed in the 8-K or exhibits provided."],"consensus_eps_estimate":0.5559,"consensus_eps_actual":-0.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":198286000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99452,"accession_number":"0000885978-26-000019","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"USPH Q1 revenue $198.3M (+7.9% YoY); GAAP loss $0.12/share, adjusted EBITDA rises to $20.2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $198.3M, up 7.9% YoY; GAAP net income $5.0M, loss per share $0.12 vs EPS $0.80 prior year.","Adjusted EBITDA $20.2M vs $19.5M; non-GAAP operating results per share $0.46 vs $0.48.","PT revenue $167.7M (+7.2%), visits up 6.9%, net rate $106.49; IIP revenue $30.6M (+11.8%).","Board declares quarterly dividend $0.46, payable June 12 to holders of record May 22.","Reaffirms FY 2026 adjusted EBITDA guidance $102M–$106M; closed $450M credit facility on April 14."],"consensus_eps_estimate":0.5559,"consensus_eps_actual":-0.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":198286000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99451,"accession_number":"0000885978-26-000017","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2026-04-15T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"USPH enters $450M credit facility with $275M revolver and $175M term loan, maturing 2031","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $450M credit facility comprises $275M revolver and $175M term loan, matures April 14, 2031.","Proceeds used to refinance existing Third Amended Credit Agreement, fund working capital, acquisitions, and growth.","Interest rates: SOFR + 1.25%-2.25% margin; commitment fee 0.225%-0.35%; initial Pricing Level 2.","Agreement includes a $125M accordion feature subject to leverage ratio ≤ 2.50:1.0."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115461,"accession_number":"0000885978-26-000014","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2026-03-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"USPH sets 2026 executive comp plans with EBITDA targets for RSUs and bonuses","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO target 12,752 RSUs; 2026 Adj. EBITDA target $105.6M; max 150% at $108.24M.","Discretionary LTIP: CEO eligible for up to 19,128 additional RSUs; President up to 8,419.","Objective Bonus Plan: CEO up to 100% of base salary; President/COO/EVP up to 75%.","All RSUs vest quarterly over 16 quarters starting May 2027; acceleration for Qualified Retirement (age 65+8 yrs)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115460,"accession_number":"0000885978-26-000011","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2026-03-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"USPH files updated investor presentation; no financial details in filing","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Investor presentation updated on March 6, 2026, available on company website.","Exhibit 99.1 contains only a disclaimer and contact info; full content not reproduced.","No new financial data, guidance, or material changes disclosed in the 8-K text.","Presentation covers company overview for year ended December 31, 2025.","Routine FD disclosure with no quantifiable impact for investors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115459,"accession_number":"0000885978-26-000009","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"USPH Q4/FY2025 earnings call transcript furnished; no specific results available from truncated text.","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Conference call transcript for Q4 and full year 2025 results was furnished as Exhibit 99.1.","Transcript excerpt in filing is incomplete; no revenue, EPS, or guidance figures were extracted.","Event is the regular quarterly earnings discussion for the period ended December 31, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115458,"accession_number":"0001140361-26-006882","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2026-02-26T23:59:59+00:00","items":["5.02","7.01","8.01","9.01"],"status":"ready","headline":"USPH reports FY2025 Adj. EBITDA $95M (+16%); CFO resigns; dividend raised to $0.46","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2025 net revenue $781M (+16.3% YoY); Adj. EBITDA $95M (+16.2%); GAAP EPS $1.42 vs $1.84 prior.","Q4 net loss per share $(0.44) due to $10.8M redeemable noncontrolling interest charge and $5.2M contingent consideration loss.","CFO Carey Hendrickson resigns effective April 24, 2026; Jason Curtis appointed interim CFO.","Quarterly dividend raised from $0.45 to $0.46 per share; payable April 10, 2026 to record March 13, 2026.","FY2026 Adj. EBITDA guidance $102M-$106M; recent acquisitions add ~$15M annual revenue."],"consensus_eps_estimate":0.68,"consensus_eps_actual":1.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":780990000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115457,"accession_number":"0000885978-26-000006","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2026-02-04T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"USPH announces $15.1M acquisition of industrial injury business and 10-year alliance with NYU Langone Health","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired 70% of industrial injury prevention business for ~$15.1M; target generates ~$7M in annual revenue.","10-year strategic alliance: Metro Physical Therapy (USPH subsidiary) joins NYU Langone network with its 60 outpatient clinics.","Alliance anticipated to become operational within the next few months.","Financial impacts of the alliance will be discussed on USPH's year-end earnings call scheduled Feb 25-26, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115456,"accession_number":"0000885978-26-000003","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2026-01-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"USPH acquires 50% stake in 8-clinic PT management firm with $8M revenue","summary_kind":"llm","event_type":"m_and_a","confidence":"medium","bullets":["Acquired 50% interest in a physical therapy management company managing eight clinics.","Target generates ~$8M in annual revenues and 66,000 visits per year.","Current owners retain the remaining 50% interest; no purchase price disclosed.","COO Graham Reeve cited expanded service offerings and strong community relationships."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131882,"accession_number":"0000885978-25-000058","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"U.S. Physical Therapy updates investor presentation on November 18, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Presentation covers company overview and is posted on USPH.com under Investor Relations.","Exhibit 99.1 contains the investor presentation for the three and nine months ended September 30, 2025.","CEO Chris Reading and CFO Carey Hendrickson listed as contacts in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131881,"accession_number":"0000885978-25-000056","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"USPH files Q3 2025 earnings call transcript but no specific results available in excerpt","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Conference call held Nov 6, 2025 to discuss Q3 2025 results; transcript furnished as Exhibit 99.1.","Provided transcript excerpt contains only introductory remarks; no financial data included.","No EPS, revenue, guidance, or segment details extractable from the furnished exhibit.","Investors should consult the full earnings release for financial results."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131880,"accession_number":"0000885978-25-000053","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"US Physical Therapy Q3 revenue up 17.8% to $168.1M; EPS $0.48; reaffirms FY2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $168.1M (+17.8% YoY); USPH Net Income $13.1M ($0.48 EPS) vs $6.6M ($0.39 EPS) prior year.","Adjusted EBITDA $23.9M (+13.2%); reaffirms FY2025 Adjusted EBITDA guidance $93-97M.","Total patient visits 1,554,207 (+18.0%); net rate per visit $105.54 (flat); record avg daily visits/clinic 32.2.","Acquired 60% of a 3-clinic practice generating ~$5.3M annual revenue; added 18 clinics net, total 779.","Board declares $0.45/share dividend payable Dec 12, 2025 (record Nov 17, 2025)."],"consensus_eps_estimate":0.6834,"consensus_eps_actual":1.85,"consensus_revenue_estimate":null,"consensus_revenue_actual":578264000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148465,"accession_number":"0000885978-25-000046","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-08-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"USPH updates investor presentation for Q2 2025; no specific data disclosed in filing","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company posted updated investor presentation on its website under IR section.","Presentation covers overview of outpatient physical therapy clinics and industrial injury prevention services.","No financial results or guidance were included in the filing; exhibit not fully provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148464,"accession_number":"0000885978-25-000044","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-08-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"USPH furnishes Q2 2025 earnings call transcript; results not in filing excerpt","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Filed under Item 7.01 Regulation FD; transcript of August 7, 2025 conference call is provided.","Provided exhibit excerpt is truncated and does not include specific financial results or guidance.","Investors should consult the full transcript or separate earnings release for Q2 2025 details.","No material new information is directly disclosed in this 8-K filing."],"consensus_eps_estimate":0.7293,"consensus_eps_actual":1.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":381132000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148463,"accession_number":"0000885978-25-000041","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"US Physical Therapy Q2 net income $12.4M; raises FY Adj EBITDA guidance to $93M-$97M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 total revenue from PT ops $168.3M (+17.3%), IIP revenue $29.1M (+22.6%); record patient visits 1.56M (+16.7%).","Net income attributable to USPH $12.4M ($0.58 EPS) vs $7.5M ($0.47); Adjusted EBITDA $26.9M (+21.4%).","Quarterly dividend $0.45/share payable Sept 12; new $25M share repurchase program authorized through Dec 2026.","Acquired 80% of a home-care practice ($2.1M annual revenue) and 60% of a 3-clinic practice ($5.3M annual revenue)."],"consensus_eps_estimate":0.7293,"consensus_eps_actual":1.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":381132000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148462,"accession_number":"0000885978-25-000037","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-08-01T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"USPH acquires 60% stake in 3-clinic PT practice with $5.3M revenue","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired 60% ownership in a physical therapy practice operating three clinic locations.","Practice currently generates approximately $5.3 million in annual revenues and 28,000 annual visits.","Current owners retain a 40% ownership interest in the practice.","Graham Reeve, Chief Operating Officer-West, welcomed the new partners."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148461,"accession_number":"0000885978-25-000032","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-07-01T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"USPH furnishes Barrington research report via Reg FD; no new material info","summary_kind":"llm","event_type":"other","confidence":"medium","bullets":["Barrington Research circulated a report on July 1, 2025, based on conversations with USPH management.","The report is furnished as Exhibit 99.1 and is not filed or incorporated by reference.","No new financial guidance, material events, or forward-looking statements were disclosed by the company.","The filing is a routine Reg FD disclosure of analyst coverage."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167283,"accession_number":"0000885978-25-000019","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-05-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"U.S. Physical Therapy dual lists common stock on NYSE Texas as Founding Member","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dual listing announced May 28, 2025; maintains primary NYSE listing with same USPH ticker.","CEO Chris Reading highlights Texas advantage in attracting talent and driving growth.","First healthcare company on NYSE Texas, per NYSE Group Chief Development Officer.","No changes to financial condition, trading structure, or shareholder rights."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167282,"accession_number":"0000885978-25-000017","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-05-20T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"US Physical Therapy shareholders elect all eight director nominees at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All eight director nominees elected; highest votes for Nancy J. Ham (13,500,869), lowest for Dr. Bernard A. Harris, Jr. (12,422,647).","Advisory vote on executive compensation approved: 12,429,355 for, 1,166,532 against, 2,075 abstain.","Ratification of Grant Thornton LLP as independent auditor for 2024 approved: 14,019,968 for, 141,515 against, 2,318 abstain.","Meeting held May 20, 2025; all three proposals passed as recommended by the board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167281,"accession_number":"0000885978-25-000014","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-05-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"US Physical Therapy files updated investor presentation for Q1 2025; no specific data disclosed in filing excerpt","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company furnished an updated investor presentation as Exhibit 99.1 on May 12, 2025.","Presentation covers Q1 2025 overview; not incorporated by reference into SEC filings.","No financial results, guidance, or material events were included in the provided exhibit text."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167280,"accession_number":"0000885978-25-000012","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-05-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"U.S. Physical Therapy holds Q1 2025 conference call; no financial details in furnished transcript excerpt","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Company hosted a conference call on May 8, 2025 to discuss Q1 2025 results.","Furnished call transcript as Exhibit 99.1; provided excerpt contains no specific financial figures.","No earnings data, guidance, or other material disclosures included in the furnished portion."],"consensus_eps_estimate":null,"consensus_eps_actual":0.8,"consensus_revenue_estimate":null,"consensus_revenue_actual":183788000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167279,"accession_number":"0000885978-25-000010","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"USPH Q1 net income $9.9M ($0.80 EPS); revenue up 16.4% to $183.8M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $9.9M ($0.80 EPS) vs $8.0M ($0.46) in Q1 2024.","PT ops revenue $156.4M (+16.4%); IIP revenue $27.4M (+28.8%).","Adjusted EBITDA $19.5M, up 16.5% from $16.8M.","Record Q1 patient visits 1,443,805; net rate $105.66/visit (+$2.29).","Declared $0.45 quarterly dividend; added 14 clinics, closed 7."],"consensus_eps_estimate":null,"consensus_eps_actual":0.8,"consensus_revenue_estimate":null,"consensus_revenue_actual":183788000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167278,"accession_number":"0000885978-25-000008","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"U.S. Physical Therapy subsidiary acquires 80% of home care practice with $2.1M revenue","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["50%-owned subsidiary MSO Metro, LLC acquired 80% interest in an outpatient home care practice.","Practice provides physical, occupational, and speech therapy; annual revenue ~$2.1 million.","Current owners retain a 20% ownership interest in the acquired company.","Expands homecare-based outpatient therapy services, primarily in the northeast."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184616,"accession_number":"0001140361-25-010807","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-03-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"USPH sets 2025 EBITDA targets for executive incentive plans: Threshold $88M, Target $91.5M, Maximum $95M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Compensation Committee approved four executive incentive plans for 2025, effective March 26, 2025.","2025 Adjusted EBITDA targets: Threshold $88M, Target $91.45M, Maximum $95M for objective LTIP and bonus.","Maximum RSAs under LTIPs: CEO 12,500 shares; President 7,500; CFO, COO West, EVP 5,000 each; vesting 16 quarters through 2030.","Objective Bonus Plan: CEO up to 100% of base salary; President, CFO, COO West, EVP up to 75% based on EBITDA.","Discretionary Bonus Plan allows up to 50% of base salary as subjective cash or RSA bonus determined by committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184615,"accession_number":"0000885978-25-000006","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-03-07T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"U.S. Physical Therapy updates investor presentation on website; no new financial details disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company posted an updated investor presentation on its website on March 7, 2025.","The presentation provides a general overview of the company's business and operations.","No specific financial results, guidance changes, or material events were announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184614,"accession_number":"0000885978-25-000004","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-03-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"USPH acquires 65% stake in Wyoming therapy practice generating $4.3M revenue","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired practice has three clinic locations in Wyoming with $4.3M annual revenue and 23,000 visits.","USPH purchased 65% interest; current owners retain 35% ownership stake.","COO Graham Reeve cited expansion of service offerings and community relationships.","Transaction was announced March 3, 2025 via press release."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184613,"accession_number":"0000885978-25-000002","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"USPH Q4 revenue up 14.2% to $180.4M; adjusted EBITDA $21.8M; dividend raised to $0.45","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenue $180.4M (PT $153.8M + IIP $26.6M), vs $154.8M prior year; full-year revenue $671.3M.","Q4 adjusted EBITDA $21.8M (+14.7% YoY); full-year adjusted EBITDA $81.8M (+5.0% YoY).","Q4 GAAP EPS $0.52 vs ($0.38); non-GAAP operating results $0.51/share vs $0.59.","Dividend raised to $0.45/share from $0.44; payable Apr 11 to holders of record Mar 14.","2025 adjusted EBITDA guidance $88M-$93M; Medicare rate cut to reduce revenue ~$6.5M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.84,"consensus_revenue_estimate":null,"consensus_revenue_actual":671345000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201198,"accession_number":"0000885978-24-000068","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-12-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"USPH acquires 75% stake in 8-clinic Wyoming hand & physical therapy practice generating $6.5M annual revenue","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired 75% interest in a hand and physical therapy practice with 8 clinic locations in Wyoming.","Practice generates approximately $6.5 million in annual revenues and 43,000 annual visits.","Current owners retain 25% ownership interest; practice becomes a USPH partner clinic.","CEO Chris Reading expressed excitement to welcome the new partners and support their patient care."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201197,"accession_number":"0000885978-24-000066","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"USPH CEO and CFO to present at two investor conferences on Nov 20, 2024","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["CEO Chris Reading to participate in Stephens Annual Investment Conference on November 20, 2024.","CFO Carey Hendrickson to present at the 16th Annual Southwest IDEAS Conference on November 20, 2024.","Presentations will provide a Company overview; no specific financial figures or guidance disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201196,"accession_number":"0000885978-24-000064","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-11-08T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"U.S. Physical Therapy provides Q3 2024 earnings call transcript; no financial specifics in excerpt","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Conference call held Nov 6, 2024 to discuss Q3 and nine months ended Sept 30, 2024.","Transcript furnished as Exhibit 99.1; investor presentation furnished as Exhibit 99.2.","Provided excerpts of exhibits do not contain specific financial results (e.g., EPS, revenue).","Filing is a routine Reg FD disclosure; no new material event beyond the call and presentation update."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201195,"accession_number":"0000885978-24-000062","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"USPH Q3: Adjusted EPS $0.55, record visits, IIP revenue up 30%, two acquisitions","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 GAAP EPS $0.39 (net income $6.6M); adjusted EPS $0.55 excluding $2.5M (net) clinic closure costs.","Record quarterly patient visits: 1,317,051 (+6% YoY); net rate per visit $105.65 (+3.2%).","Adjusted EBITDA $21.1M (up from $18.6M); IIP revenue $25.3M (+29.9%).","Acquired 70% of 8-clinic practice (Aug 31) and 50% of MSO managing 50 clinics (Oct 31) with $64M annual revenue.","Dividend declared $0.44/share, payable Dec 6, record Nov 15."],"consensus_eps_estimate":null,"consensus_eps_actual":1.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":490898000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201194,"accession_number":"0000885978-24-000059","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-11-01T23:59:59+00:00","items":["3.02","8.01","5.02","7.01","9.01"],"status":"ready","headline":"USPH closes $76.5M acquisition of 50% interest in Metro, 50-clinic operator","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Paid ~$76.5M: $75M cash plus 18,358 shares of USPH common stock.","Metro-managed clinics generate ~$64M annual revenue and ~$12M annual EBITDA.","Earnout provision allows up to $20M additional if performance targets are met.","Board expanded to 8; Michael G. Mayrsohn (Metro CEO) appointed as director.","Clinics primarily in New York, with plans for further expansion in NY and adjacent states."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201193,"accession_number":"0000885978-24-000056","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-10-07T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"U.S. Physical Therapy acquires 50% stake in 50-clinic MSO for $76.5M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $76.5M ($75M cash + $1.5M in USPH stock); sellers can earn up to $20M additional earnout based on performance.","Managed clinics generate ~$64M annual revenue and ~$12M annual EBITDA; majority in New York with plans for regional expansion.","Existing owners retain 50% interest; CEO who grew clinics from 5 to 50 will continue as executive leader.","Expected close October 31, 2024, subject to customary conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217218,"accession_number":"0000885978-24-000054","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-09-03T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"US Physical Therapy acquires 70% stake in 8-clinic PA practice with $5.5M revenue","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired 70% interest in a Pennsylvania physical and hand therapy practice.","Practice operates eight clinic locations and generates ~$5.5 million in annual revenues.","Current owners retain a 30% ownership interest; no further financial terms disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217217,"accession_number":"0000885978-24-000052","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-08-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"USPH CEO to present at Midwest IDEAS Investor Conference on Aug 28, 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Chris Reading, Chairman and CEO, will present at the 15th Annual Midwest IDEAS Investor Conference.","The presentation will provide an overview of the Company's operations and strategy.","The conference takes place on Wednesday, August 28, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217216,"accession_number":"0000885978-24-000050","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-08-16T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"USPH furnishes Q2 2024 conference call transcript and investor presentation","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filed under Item 7.01 Regulation FD; transcript of August 14 call discussing Q2 2024 results.","Investor presentation updated; no specific financial metrics provided in the filing text.","Documents are furnished, not filed; not incorporated by reference into SEC filings.","No new material disclosures beyond previously reported earnings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217215,"accession_number":"0000885978-24-000048","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-08-14T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"USPH Q2 revenue up 8.5% to $143.5M; EPS $0.47 vs $0.64; guidance reaffirmed at $80-85M EBITDA","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $7.5M ($0.47 diluted EPS) vs $10.9M ($0.64) in Q2 2023; share count up from May 2023 secondary offering.","Adjusted EBITDA $22.1M vs $21.7M; non-GAAP Operating Results $0.73/share vs $0.76.","Total patient visits hit all-time quarterly high of 1,335,335, up 5.4%; net rate per visit $105.05 (+3.0%).","Industrial injury prevention revenue up 23.2% to $23.7M; acquired an IIP business for $24M on April 30, 2024.","Quarterly dividend $0.44/share declared (payable Sep 13, record Aug 23); clinic count 681 vs 656 a year ago."],"consensus_eps_estimate":null,"consensus_eps_actual":0.93,"consensus_revenue_estimate":null,"consensus_revenue_actual":322865000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217214,"accession_number":"0000885978-24-000045","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-07-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"USPH CEO to present at CJS Securities New Ideas Conference on July 10","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Chris Reading will present at the CJS Securities 24th Annual New Ideas Summer Conference on Wed, July 10, 2024.","Presentation will cover a general overview of the company's operations and strategy.","No financial results or guidance disclosed in this announcement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236999,"accession_number":"0000885978-24-000043","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-06-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CEO Chris Reading to present at East Coast IDEAS Conference on June 12, 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Chris Reading, CEO, will present at the 14th Annual East Coast IDEAS Conference 2024.","Presentation is scheduled for Wednesday, June 12, 2024, covering a company overview.","Press release announcing the conference participation was issued on June 5, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236998,"accession_number":"0000885978-24-000041","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-05-31T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"USPH amends executive severance to add pro rata incentive awards for five officers","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amended employment agreements for CEO Reading, President Williams, COO Reeve, CFO Hendrickson, GC Binstein.","Enhanced severance: two years base pay plus greater of last year bonus or three-year average bonus.","New: pro rata portion of subjective and objective incentive plan awards in year of termination.","All restricted stock owned by executive vests immediately upon termination without cause or for good reason.","For COO Reeve, change-of-control benefit of $283,333 added; effective date May 27, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236997,"accession_number":"0000885978-24-000036","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-05-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"USPH CFO to present at Jefferies Global Healthcare Conference on June 5, 2024","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["CFO Carey Hendrickson will present at the Jefferies Global Healthcare Conference on June 5, 2024.","Presentation will provide an overview of the company's operations and strategy.","No new financial guidance or material business developments disclosed in the announcement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236996,"accession_number":"0000885978-24-000033","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-05-21T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"U.S. Physical Therapy appoints CEO Reading as Chairman, promotes Williams to President","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Christopher Reading, CEO since 2004, named Chairman effective May 21; replaces Edward Kuntz (retired).","Eric Williams promoted to President, retains role as COO-East.","Dr. Bernard Harris appointed Lead Independent Director.","All seven director nominees elected; Say-on-Pay and auditor ratification approved by stockholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236995,"accession_number":"0000885978-24-000031","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"USPH CEO and CFO to present at Bank of America Healthcare Conference on May 14","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Chris Reading (CEO) and Carey Hendrickson (CFO) will present at the Bank of America Securities Healthcare Conference 2024.","Presentation scheduled for Tuesday, May 14, 2024, covering an overview of the Company.","No financial results, guidance changes, or material disclosures announced in conjunction with the presentation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236994,"accession_number":"0000885978-24-000030","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"USPH holds Q1 2024 earnings call; Eric Williams named President","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Q1 2024 financial results discussed on May 8 call; specific figures not in this exhibit.","Eric Williams, current COO East, promoted to President effective after May annual meeting.","Chris Reading remains CEO; leadership transition part of planned succession."],"consensus_eps_estimate":null,"consensus_eps_actual":0.46,"consensus_revenue_estimate":null,"consensus_revenue_actual":155675000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236993,"accession_number":"0000885978-24-000026","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"US Physical Therapy Q1 revenue up 4.1%, EPS $0.46; raises FY 2024 EBITDA guidance to $82.5M-$87.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 2024 net income $8.0M ($0.46 EPS) vs $7.4M ($0.58 EPS) in prior year; adjusted EBITDA $16.7M.","Revenue from PT operations $134.4M (+4.1% YoY); IIP revenue $21.3M (+9.8%).","Management raises full-year 2024 Adjusted EBITDA guidance to $82.5M-$87.5M, citing improved Medicare rates and strong Feb/March volumes.","Two acquisitions: 50% stake in nine-clinic PT practice ($16.4M) and 100% of IIP services business ($24.0M, after quarter end).","Quarterly dividend of $0.44 per share declared, payable June 14, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":0.46,"consensus_revenue_estimate":null,"consensus_revenue_actual":155675000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236992,"accession_number":"0000885978-24-000024","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-05-06T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"USPH re-appoints Compensation Committee; Swanson steps down over independence feedback","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board re-appointed Compensation Committee: Kathleen Gilmartin (Chair), Anne Motsenbocker, Edward Kuntz.","Director Regg Swanson relinquished committee seat after stockholder feedback preferring 5-year independence.","Swanson has been an independent director since February 1, 2020, but only about 4 years."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236991,"accession_number":"0000885978-24-000022","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"U.S. Physical Therapy clarifies director independence for Regg Swanson's re-election","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Regg Swanson nominated for re-election as director at May 21, 2024 annual meeting.","Swanson was employed by subsidiary Star PT from 2007 to Jan 31, 2020 with no officer or business-unit role.","His role in 2019-2020 was limited to customer relations; company affirms independence since 2019.","Proxy statement dated April 15, 2024 lists Swanson as an independent director."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236990,"accession_number":"0000885978-24-000020","cik":885978,"company_name":"U S PHYSICAL THERAPY INC /NV","ticker":"USPH","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"U.S. Physical Therapy buys IIP business for ~$24M and a two-clinic PT practice","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Briotix subsidiary acquired an IIP services business for ~$24.0M; annual revenue ~$11.0M.","Separate tuck-in acquisition of a two-clinic PT practice with ~$1.0M annual revenue.","CEO expects new verticals in transportation, construction, manufacturing and cross-selling of Briotix programs.","Acquisitions funded from existing resources, no debt or equity issuance disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":937630000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2024-05-01T23:59:59+00:00|236990"}